Amphastar Pharmaceuticals (AMPH) Inventory Average (2014 - 2026)

Amphastar Pharmaceuticals' Inventory Average history runs 13 years deep, the most recent figure standing at $173.5 million for Q1 2026.

• On a quarterly basis, Inventory Average rose 2.32% year-over-year to $173.5 million in Q1 2026; TTM through Mar 2026 was $173.5 million, a 2.32% increase from a year earlier, with the FY2025 full-year figure at $165.3 million, up 27.37% from the prior year.
• Inventory Average retreated to $173.5 million in Q1 2026 per AMPH's latest filing, from $181.4 million in the prior quarter.
• Across five years, Inventory Average topped out at $188.8 million in Q3 2025 and bottomed at $94.0 million in Q1 2022.
• The 5-year median for Inventory Average is $110.7 million (2024), against an average of $130.5 million.
• Across the five-year window, Inventory Average slipped 3.09% in 2022 and jumped 58.55% in 2025, its largest moves.
• Year by year, Inventory Average stood at $103.4 million in 2022, then gained by 4.34% to $107.9 million in 2023, then soared by 31.62% to $142.0 million in 2024, then grew by 27.73% to $181.4 million in 2025, then retreated by 4.34% to $173.5 million in 2026.
• Per Business Quant, the three latest AMPH Inventory Average figures stand at $173.5 million (Q1 2026), $181.4 million (Q4 2025), and $188.8 million (Q3 2025).